tradingkey.logo
検索
マーケット
ニュース
分析
ツール
株式スクリーナー
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
検索

Vyne Therapeutics Inc

VYNE
ウォッチリストに追加
0.670USD
-0.000-0.07%
終値 05/15, 16:00（ET）15分遅れの株価
21.28M時価総額
損失額直近12ヶ月PER

Vyne Therapeutics Inc

0.670
-0.000-0.07%
概要金融ディスカッション分析企業名

概要

金融

ディスカッション

分析

企業名

詳細情報 Vyne Therapeutics Inc 企業名

VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need. Its lead program is repibresib gel (also known as VYN201), a topically administered, small-molecule pan-BD bromodomain and extra-terminal (BET) inhibitor designed as a soft drug to address diseases involving multiple, diverse inflammatory cell signaling pathways while providing low systemic exposure. Its second program is VYN202, an oral, small-molecule BD2-selective BET inhibitor. The Company has rights to research, develop and commercialize products containing BET inhibitor compounds for the treatment of any disease, disorder or condition in humans. Utilizing its InhiBET platform and through its preclinical and clinical activities, the Company is evaluating the impact that BET inhibitor compounds have on regulating pro-inflammatory cytokines.

Vyne Therapeutics Incの企業情報

企業コードVYNE
会社名Vyne Therapeutics Inc
上場日Jan 25, 2018
最高経営責任者「CEO」Domzalski (David)
従業員数13
証券種類Ordinary Share
決算期末Jan 25
本社所在地685 Route 202/206 N., Suite 301
都市BRIDGEWATER
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号08807
電話番号18007757936
ウェブサイトhttps://vynetherapeutics.com/
企業コードVYNE
上場日Jan 25, 2018
最高経営責任者「CEO」Domzalski (David)

Vyne Therapeutics Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Tyler Zeronda
Mr. Tyler Zeronda
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
100.91K
-3.97%
Ms. Mutya Fonte Harsch, J.D.
Ms. Mutya Fonte Harsch, J.D.
Chief Legal Officer, General Counsel, Secretary
Chief Legal Officer, General Counsel, Secretary
55.23K
-7.25%
Dr. Iain Stuart, Ph.D.
Dr. Iain Stuart, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
47.05K
-6.11%
Mr. Steven L. Basta
Mr. Steven L. Basta
Independent Director
Independent Director
7.45K
--
Ms. Elisabeth A. Sandoval Little
Ms. Elisabeth A. Sandoval Little
Independent Director
Independent Director
--
--
Mr. David Domzalski
Mr. David Domzalski
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Sharon Barbari
Ms. Sharon Barbari
Independent Director
Independent Director
--
--
Mr. Patrick G. Lepore
Mr. Patrick G. Lepore
Lead Independent Director
Lead Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Tyler Zeronda
Mr. Tyler Zeronda
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
100.91K
-3.97%
Ms. Mutya Fonte Harsch, J.D.
Ms. Mutya Fonte Harsch, J.D.
Chief Legal Officer, General Counsel, Secretary
Chief Legal Officer, General Counsel, Secretary
55.23K
-7.25%
Dr. Iain Stuart, Ph.D.
Dr. Iain Stuart, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
47.05K
-6.11%
Mr. Steven L. Basta
Mr. Steven L. Basta
Independent Director
Independent Director
7.45K
--
Ms. Elisabeth A. Sandoval Little
Ms. Elisabeth A. Sandoval Little
Independent Director
Independent Director
--
--
Mr. David Domzalski
Mr. David Domzalski
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

収益内訳

通貨: USD更新時刻: Mon, Apr 6
通貨: USD更新時刻: Mon, Apr 6
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
事業別USD
会社名
収益
比率
Royalty revenues
570.00K
0.00%
会社から関連データがまだ開示されていません。
事業別
地域別
事業別USD
会社名
収益
比率
Royalty revenues
570.00K
0.00%

株主

更新時刻: Sun, May 10
更新時刻: Sun, May 10
株主統計
種類
株主統計
株主統計
比率
Lynx1 Capital Advisors LLC
4.89%
Shay Capital LLC
4.87%
Anson Funds Management LP.
3.82%
Access Industries, Inc.
3.35%
Nantahala Capital Management, LLC
3.00%
他の
80.06%
株主統計
株主統計
比率
Lynx1 Capital Advisors LLC
4.89%
Shay Capital LLC
4.87%
Anson Funds Management LP.
3.82%
Access Industries, Inc.
3.35%
Nantahala Capital Management, LLC
3.00%
他の
80.06%
種類
株主統計
比率
Hedge Fund
17.05%
Investment Advisor
11.66%
Corporation
3.35%
Investment Advisor/Hedge Fund
3.07%
Individual Investor
1.29%
Research Firm
0.30%
Venture Capital
0.24%
他の
63.04%

機関投資家保有株

更新時刻: Wed, Apr 1
更新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q1
92
11.08M
33.26%
-1.67M
2025Q4
88
4.87M
14.64%
-6.85M
2025Q3
84
8.51M
25.77%
-898.65K
2025Q2
84
9.46M
56.76%
-1.30M
2025Q1
81
9.36M
56.20%
-1.38M
2024Q4
92
9.37M
63.49%
-533.87K
2024Q3
88
8.98M
61.30%
-594.32K
2024Q2
89
9.65M
66.73%
+287.65K
2024Q1
92
9.64M
67.66%
+101.95K
2023Q4
101
10.22M
72.71%
+4.63M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Shay Capital LLC
1.62M
4.87%
+1.13M
+229.77%
Dec 31, 2025
Anson Funds Management LP.
1.27M
3.82%
+1.27M
--
Dec 31, 2025
Access Industries, Inc.
1.12M
3.35%
--
--
Dec 31, 2025
Nantahala Capital Management, LLC
1.00M
3%
+1.00M
--
Dec 31, 2025
T3 Companies, LLC
945.00K
2.84%
+945.00K
--
Dec 31, 2025
Delaware Street Capital, L.L.C.
696.47K
2.09%
--
--
Sep 30, 2024
Acadian Asset Management LLC
638.49K
1.92%
+192.08K
+43.03%
Dec 31, 2025
KVP Capital Advisors, LP
500.55K
1.5%
+500.55K
--
Dec 31, 2025
Two Sigma Investments, LP
383.10K
1.15%
+105.71K
+38.11%
Dec 31, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
Feb 10, 2023
Merger
18→1
Feb 10, 2023
Merger
18→1
Feb 10, 2023
Merger
18→1
Feb 10, 2023
Merger
18→1
Feb 12, 2021
Merger
4→1
Feb 12, 2021
Merger
4→1
日付
配当落ち日
種類
比率
Feb 10, 2023
Merger
18→1
Feb 10, 2023
Merger
18→1
Feb 10, 2023
Merger
18→1
Feb 10, 2023
Merger
18→1
Feb 12, 2021
Merger
4→1
Feb 12, 2021
Merger
4→1
Feb 12, 2021
Merger
4→1
Feb 12, 2021
Merger
4→1
KeyAI